(1)
Bang, C. H. .; Oh, H. J.; Kim, Y. H.; Jung, J.-H.; Lee, J. H. .; Park, Y. M.; Han, J. H. Ustekinumab Demonstrates Lower Uveitis Risk in Moderate to Severe Psoriasis Patients Compared With Tumor Necrosis Factor-α Inhibitors. Acta Derm Venereol 2024, 104, adv34206.